Results 1 to 10 of about 5,373,856 (290)

Verbascoside promotes the regeneration of tyrosine hydroxylase-immunoreactive neurons in the substantia nigra

open access: yesNeural Regeneration Research, 2016
Tyrosine hydroxylase is a key enzyme in dopamine biosynthesis. Change in tyrosine hydroxylase expression in the nigrostriatal system is closely related to the occurrence and development of Parkinson′s disease.
Jian-qing Liang   +3 more
doaj   +1 more source

The role of the brain renin-angiotensin system in Parkinson´s disease

open access: yesTranslational Neurodegeneration
The renin-angiotensin system (RAS) was classically considered a circulating hormonal system that regulates blood pressure. However, different tissues and organs, including the brain, have a local paracrine RAS.
Jose Luis Labandeira-Garcia   +3 more
doaj   +1 more source

Measuring the Burden of Hospitalization in Patients with Parkinson´s Disease in Spain.

open access: yesPLoS ONE, 2016
IntroductionThis epidemiological survey estimates the hospitalization burden related to Parkinson´s Disease in Spain.MethodsThis observational retrospective survey was performed by reviewing data from the National Surveillance System for Hospital Data ...
Ruth Gil-Prieto   +5 more
doaj   +1 more source

Utility of manual fractional anisotropy measurements in the management of patients with Parkinson disease: a feasibility study with a 1.5-T magnetic resonance imaging system

open access: yesActa Radiologica Open, 2021
Background Diffusion tensor imaging has emerged as a promising tool for quantitative analysis of neuronal damage in Parkinson disease, with potential value for diagnostic and prognostic evaluation.
Romulo V de Oliveira, João S Pereira
doaj   +1 more source

Feasibility of a Pharmabuddy Care Service for patients with Parkinson’s disease

open access: yesBMC Health Services Research
Background Pharmaceutical care for patients with Parkinson’s disease (PD) is complex. Specialized pharmaceutical care provided by a dedicated pharmacy team member (pharmabuddy) for these patients may reduce medication-related problems. The feasibility of
C. C. M. Stuijt   +5 more
doaj   +1 more source

Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease

open access: yesAnnals of Clinical and Translational Neurology, 2020
Objective To determine the evolution of numerous neuropsychiatric symptoms and cognitive abilities in Parkinson disease from disease onset. Methods Prospectively collected, longitudinal (untreated, disease onset to year 5), observational data from ...
Daniel Weintraub   +19 more
doaj   +1 more source

Inhibition of Protease-Activated Receptor-2 Activation in Parkinson’s Disease Using 1-Piperidin Propionic Acid

open access: yesBiomedicines
In Parkinson’s disease, neuroinflammation is a double-edged sword; when inflammation occurs it can have harmful effects, despite its important role in battling infections and healing tissue.
Santina Quarta   +7 more
doaj   +1 more source

Gastrointestinal Biopsies for the Diagnosis of Alpha-Synuclein Pathology in Parkinson’s Disease

open access: yesGastroenterology Research and Practice, 2015
The diagnosis of Parkinson’s disease (PD) relies on clinical features whereas pathological confirmation is only possible with autopsy examination. The neuropathological hallmarks of PD are neuronal loss and the presence of inclusions termed Lewy bodies ...
Maria Graciela Cersosimo
doaj   +1 more source

Parkinsonism induced by carbon monoxide intoxication: A “hidden gem” in the neurological literature

open access: yesJournal of Parkinson’s Disease
Parkinsonism can be acquired by various toxic exposures, among them carbon monoxide. Since the publication of a 1972 report of Parkinsonism associated with repeated episodes of carbon monoxide exposure, the medical literature has recorded multiple cases.
Omer Abdullah, Peter A. LeWitt
doaj   +1 more source

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors

open access: yesTranslational Neurodegeneration, 2019
Background IgG-class autoantibodies to N-Methyl-D-Aspartate (NMDA)-type glutamate receptors define a novel entity of autoimmune encephalitis. Studies examining the prevalence of NMDA IgA/IgM antibodies in patients with Parkinson disease with/without ...
Franziska Hopfner   +32 more
doaj   +1 more source

Home - About - Disclaimer - Privacy